Abstract:Background Heterogeneity of endothelial cells (ECs) is a hallmark of the vascular system which may impact the development and management of vascular disorders. Despite the tremendous progress in differentiation of human embryonic stem cells (hESCs) towards endothelial lineage, differentiation into arterial and venous endothelial phenotypes remains elusive. Additionally, current differentiation strategies are hampered by inefficiency, lack of reproducibility, and use of animal-derived products. Methods To direct the differentiation of hESCs to endothelial subtypes, H1- and H9-hESCs were seeded on human plasma fibronectin and differentiated under chemically defined conditions by sequential modulation of glycogen synthase kinase-3 (GSK-3), basic fibroblast growth factor (bFGF), bone morphogenetic protein 4 (BMP4) and vascular endothelial growth factor (VEGF) signaling pathways for 5 days. Following the initial differentiation, the endothelial progenitor cells (CD34 + CD31 + cells) were sorted and terminally differentiated under serum-free conditions to arterial and venous ECs. The transcriptome and secretome profiles of the two distinct populations of hESC-derived arterial and venous ECs were characterized. Furthermore, the safety and functionality of these cells upon in vivo transplantation were characterized. Results Sequential modulation of hESCs with GSK-3 inhibitor, bFGF, BMP4 and VEGF resulted in stages reminiscent of primitive streak, early mesoderm/lateral plate mesoderm, and endothelial progenitors under feeder- and serum-free conditions. Furthermore, these endothelial progenitors demonstrated differentiation potential to almost pure populations of arterial and venous endothelial phenotypes under serum-free conditions. Specifically, the endothelial progenitors differentiated to venous ECs in the absence of VEGF, and to arterial phenotype under low concentrations of VEGF. Additionally, these hESC-derived arterial and venous ECs showed distinct molecular and functional profiles in vitro. Furthermore, these hESC-derived arterial and venous ECs were nontumorigenic and were functional in terms of forming perfused microvascular channels upon subcutaneous implantation in the mouse. Conclusions We report a simple, rapid, and efficient protocol for directed differentiation of hESCs into endothelial progenitor cells capable of differentiation to arterial and venous ECs under feeder-free and serum-free conditions. This could offer a human platform to study arterial–venous specification for various applications related to drug discovery, disease modeling and regenerative medicine in the future.

ETV2 expression increases the efficiency of primitive endothelial cell derivation from human embryonic stem cells

Directing Endothelial Differentiation of Human Embryonic Stem Cells Via Transduction with an Adenoviral Vector Expressing the VEGF165 Gene

Abstract 17503: ETV2 Functions as a Pioneer Factor and Regulates the Endothelial Lineage

ETV2 and VEZF1 Interaction and Regulation of the Hematoendothelial Lineage During Embryogenesis

ETV2 Transcriptionally Activates Rig1 Gene Expression and Promotes Reprogramming of the Endothelial Lineage

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

Abstract 16723: Complementation of Mutant Embryos Demonstrates a Cell Autonomous Requirement of Etv2

Transdifferentiation of Fast Skeletal Muscle Into Functional Endothelium in Vivo by Transcription Factor Etv2

ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage

Feedback Mechanisms Regulate Ets Variant 2 (etv2) Gene Expression and Hematoendothelial Lineages

ETV2 induces endothelial, but not hematopoietic, lineage specification in birds

ETV2/ER71 regulates the generation of FLK1+ cells from mouse embryonic stem cells through miR-126-MAPK signaling

Differential Etv2 threshold requirement for endothelial and erythropoietic development

Efficiently Induce Endothelial Progenitor Cells from Human Embryonic Stem Cells

Sox7 is Regulated by ETV2 During Cardiovascular Development.

Etv2 is expressed in the yolk sac hematopoietic and endothelial progenitors and regulates Lmo2 gene expression.

cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential

Etsrp/Etv2 is Directly Regulated by Foxc1a/b in the Zebrafish Angioblast

Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells

Abstract Tu013: ETV2 Transcriptionally Activates Rig1 Gene Expression and Promotes Reprogramming of the Endothelial Lineage

Single-cell transcriptomic analysis identifies the conversion of zebrafish Etv2-deficient vascular progenitors into skeletal muscle